ReP USP - Resultado da busca

Artigo de periodico
Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents (2020)
Cianni, Lorenzo ; Lemke, Carina; Gilberg, Erik; Feldmann, Christian; Rosini, Fabiana; Rocho, Fernanda dos Reis ; Ribeiro, Jean Francisco Rosa; Tezuka, Daiane Yukie; Lopes, Carla Duque ; Albuquerque, Sérgio de ; Bajorath, Jürgen; Laufer, Stefan; Leitão, Andrei ; Gütschow Michaell; Montanari, Carlos Alberto
Source: PLoS Neglected Tropical Diseases. Unidades: IQSC, FCFRP, FMRP
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIANNI, Lorenzo et al. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. PLoS Neglected Tropical Diseases, v. 14, n. 3, p. 1-36, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0007755. Acesso em: 24 dez. 2024.
APA
Cianni, L., Lemke, C., Gilberg, E., Feldmann, C., Rosini, F., Rocho, F. dos R., et al. (2020). Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. PLoS Neglected Tropical Diseases, 14( 3), 1-36. doi:10.1371/journal.pntd.0007755
NLM
Cianni L, Lemke C, Gilberg E, Feldmann C, Rosini F, Rocho F dos R, Ribeiro JFR, Tezuka DY, Lopes CD, Albuquerque S de, Bajorath J, Laufer S, Leitão A, Gütschow Michaell, Montanari CA. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 3): 1-36.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1371/journal.pntd.0007755
Vancouver
Cianni L, Lemke C, Gilberg E, Feldmann C, Rosini F, Rocho F dos R, Ribeiro JFR, Tezuka DY, Lopes CD, Albuquerque S de, Bajorath J, Laufer S, Leitão A, Gütschow Michaell, Montanari CA. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 3): 1-36.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1371/journal.pntd.0007755
Artigo de periodico
Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease (2019)
Lopes, Carla Duque ; Possato, Bruna ; Gaspari, Ana Paula Segantin ; Oliveira, Ronaldo Junio ; Abram, Ulrich ; Almeida, José P. A; Rocho, Fernanda dos Reis ; Leitão, Andrei ; Montanari, Carlos Alberto ; Maia, Pedro Ivo da Silva ; Silva, João Santana da ; Albuquerque, Sérgio de ; Carneiro, Zumira Aparecida
Source: ACS Infectious Diseases. Unidades: IQSC, FMRP, FCFRP
Subjects: BIOQUÍMICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Carla Duque et al. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, v. 5, n. 10, p. 1698-1707, 2019Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.8b00284. Acesso em: 24 dez. 2024.
APA
Lopes, C. D., Possato, B., Gaspari, A. P. S., Oliveira, R. J., Abram, U., Almeida, J. P. A., et al. (2019). Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, 5( 10), 1698-1707. doi:10.1021/acsinfecdis.8b00284
NLM
Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284
Vancouver
Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284
Artigo de periodico
Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? (2019)
Cianni, Lorenzo ; Feldmann, CW; Gilberg, E; Gütschow Michaell; Juliano, Luiz; Leitão, Andrei ; Bajorath, Jurgen; Montanari, Carlos Alberto
Source: Journal of Medicinal Chemistry. Unidade: IQSC
Assunto: NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIANNI, Lorenzo et al. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?. Journal of Medicinal Chemistry, v. 62, n. 23, p. 10497-10525 july, 2019Tradução . . Disponível em: https://doi.org/10.1021/acs.jmedchem.9b00683. Acesso em: 24 dez. 2024.
APA
Cianni, L., Feldmann, C. W., Gilberg, E., Gütschow Michaell,, Juliano, L., Leitão, A., et al. (2019). Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? Journal of Medicinal Chemistry, 62( 23), 10497-10525 july. doi:10.1021/acs.jmedchem.9b00683
NLM
Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683
Vancouver
Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2024 dez. 24 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Indexado em

Non normalized affiliation